Emirates Biotech has selected Sulzer as the technology provider for its upcoming Polylactic Acid (PLA) production plant in the UAE. 

 

The facility will be constructed in two phases, each with an annual capacity of 80,000 tonnes, resulting in a total production capacity of 160,000 tonnes per annum. Once completed, it will be the largest PLA production facility in the world. Supporting regional and global efforts to combat plastic pollution and climate change, this volume of bioplastic material is enough to replace approximately 3.2 billion plastic bottles and will reduce CO2 emissions by over 300,000 tonnes annually.

 

Construction is set to commence in 2025, with the plant expected to be operational by early 2028. The facility will use Lactic Acid (LA) as its feedstock to produce PLA, offering a low-carbon footprint and biodegradable alternatives to conventional plastics, further contributing to the circular economy.

 

Sustainable alternative

PLA offers a sustainable alternative to traditional plastics. It is widely used in applications such as packaging, disposable utensils, helping to reduce reliance on single-use plastics across the globe. Emirates Biotech will leverage Sulzer’s licensed PLA technology to manage all production steps from a single location, including lactide production, purification and polymerisation. The facility will also use a plant-based feedstock to produce high-quality PLA bioplastics at scale, positioning the Middle East as a key player in the bioplastics industry.

 

With over two centuries of industry experience and a strong track record in the bioplastics sector, Sulzer’s licensed PLA technology is already in use at most PLA facilities worldwide. This new development strengthens Sulzer’s commitment to supporting global industry in adopting circular manufacturing and building a more prosperous and sustainable society.

 

Shaikh Suhail Ali Saeed Rashed Al-Maktoum, a key shareholder of Emirates Biotech, commented: “This project highlights our commitment to sustainability and economic diversification. By leveraging innovative technologies and strategic partnerships, we aim to establish the UAE as a global leader in the production of eco-friendly materials.”

 

Key milestone

Marc Verbruggen, CEO of Emirates Biotech, said: “Our partnership with Sulzer marks a key milestone in our journey to establish a world-class PLA production facility. Sulzer’s expertise and innovative solutions will be crucial in achieving our vision of leading the biopolymer industry while contributing to a more sustainable future.”

 

“We are proud to collaborate with Sulzer on this groundbreaking project.” Dorus Everwijn President of GBI, a key shareholder of Emirates Biotech, added. “Sulzer’s advanced technologies and extensive experience in the PLA industry will support the development of a state-of-the-art PLA production facility, setting new benchmarks.”

 

Tim Schulten, Division President of Chemtech, said: “We are thrilled to partner with Emirates Biotech on this groundbreaking project. By bringing our advanced PLA production technology to the UAE, we are supporting the region’s transition to more sustainable materials and contributing to a greener future.”

 

Emmanuel Rapendy, Global Head Polymers and Crystallisation for Sulzer Chemtech, continues: “This project is extremely important as environmental challenges are highlighting the need for the global adoption of biopolymers. Further, it emphasises our ethos of tackling sustainability from the ground up. Not only are we enabling cleaner processes and end products with our technologies, we also ensure that our equipment and systems have a very high degree of efficiency, limiting the energy input required for operation.” 

 

As the global demand for PLA continues to rise, driven by environmental concerns and the shift towards sustainable materials, this facility will position the Middle East as a key player in the bioplastics industry, supporting regional and global efforts to combat plastic pollution.--TradeArabia News Service